Winton Group’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37,927
Closed -$188K 1092
2022
Q4
$188K Buy
37,927
+7,045
+23% +$38.2K 0.01% 872
2022
Q3
$148K Buy
30,882
+3,150
+11% +$16.6K 0.01% 887
2022
Q2
$125K Sell
27,732
-54,473
-66% -$237K 0.01% 918
2022
Q1
$391K Buy
+82,205
New +$455K 0.02% 749

Other funds holding IMGN

Winton Group's IMGN Position: Q1 2023 in Review

Winton Group sold out of Immunogen Inc (IMGN) in Q1 2023, closing a stake of 37,927 shares — an estimated $188K sold.

Winton Group first reported a position in IMGN in Q1 2022 and held it in 4 quarters. The position peaked at $391K in Q1 2022. 190 funds tracked by Wall St. Rank hold IMGN as of Q1 2023.

  • Winton Group reported no remaining Immunogen Inc position as of Q1 2023 after selling out during the quarter.
  • Winton Group sold 37,927 Immunogen Inc shares in Q1 2023, an estimated $188K.
  • Winton Group first reported a position in Immunogen Inc in Q1 2022 and held it in 4 quarters.
  • Winton Group's Immunogen Inc position peaked at $391K in Q1 2022.
  • 190 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2023.

Based on Winton Group's 13F filing for Q1 2023, filed 12 May 2023.